Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
293,061,432
-
Total 13F shares
-
108,113,334
-
Share change
-
+3,833,772
-
Total reported value
-
$369,573,317
-
Put/Call ratio
-
56%
-
Price per share
-
$3.42
-
Number of holders
-
142
-
Value change
-
-$11,116,504
-
Number of buys
-
73
-
Number of sells
-
65
Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q4 2025
As of 31 Dec 2025,
AbCellera Biologics Inc. - Ordinary Shares (ABCL) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,113,334 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital World Investors, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, GOLDMAN SACHS GROUP INC, ArrowMark Colorado Holdings LLC, BlackRock, Inc., Driehaus Capital Management LLC, and MORGAN STANLEY.
This page lists
142
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.